Search all trials

Find therapies in clinical trials near you – page 17

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

A Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Alcohol use disorder

Not recruiting

Investigational

A Study of Brenipatide Compared to Placebo in Adults with Moderate-to-Severe Alcohol Use Disorder

Investigational

Germany

Participants:18–64 years
Substances:LY3537031

Contact Research Centre

Malignant melanoma stage IV+1

Not recruiting

Registered drugNo placebo

Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Acasunlimab

Contact Research Centre

Acute myocardial infarction

Not recruiting

Investigational

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Ziltivekimab

Contact Research Centre

Non-small cell lung cancer stage IV+1

Not recruiting

InvestigationalNo placebo

Study of Zelenectide Pevedotin in Adults with Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer with NECTIN4 Amplification

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:ZELENECTIDE PEVEDOTIN

Contact Research Centre

Arteriosclerosis

Not recruiting

Registered drug

Study of pelacarsen and inclisiran in patients with atherosclerotic cardiovascular disease who have high levels of LDL cholesterol and lipoprotein(a)

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Inclisiran

Contact Research Centre

Activated PI3 kinase delta syndrome

Not recruiting

InvestigationalNo placebo

Study on the Effects of Leniolisib in Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome

InvestigationalNo placebo

Germany

Participants:18–64 years · Healthy volunteers
Substances:Leniolisib Phosphate

Contact Research Centre

Meningitis meningococcal

Not recruiting

Investigational

Study on the Safety and Immune Response of MenABCWY Vaccine in Healthy Adolescents Aged 11-14 with Meningococcal Meningitis

Investigational

Germany

Participants:0–17 years · Healthy volunteers
Substances:MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN

Contact Research Centre

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan and Drug Combination for Patients with HER2-Positive Gastric, GEJ, and Esophageal Cancer

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan and Drug Combination for Patients with HER2-Positive Gastric, GEJ, and Esophageal Cancer

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:Capecitabine

Contact Research Centre

Primary myelofibrosis

Not recruiting

Registered drugNo placebo

Study of Momelotinib and Luspatercept for Patients with Transfusion-Dependent Myelofibrosis

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Glioma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Vorasidenib and Temozolomide for Patients with IDH1 or IDH2 Mutant Glioma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Temozolomide

Contact Research Centre

Find therapies in clinical trials near you – page 17

352 trials match your criteria

Colorectal cancer metastatic

A Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer

Alcohol use disorder

A Study of Brenipatide Compared to Placebo in Adults with Moderate-to-Severe Alcohol Use Disorder

Malignant melanoma stage IV+1

Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies

Malignant melanoma

Study of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment

Acute myocardial infarction

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Non-small cell lung cancer stage IV+1

Study of Zelenectide Pevedotin in Adults with Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer with NECTIN4 Amplification

Arteriosclerosis

Study of pelacarsen and inclisiran in patients with atherosclerotic cardiovascular disease who have high levels of LDL cholesterol and lipoprotein(a)

Activated PI3 kinase delta syndrome

Study on the Effects of Leniolisib in Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome

Meningitis meningococcal

Study on the Safety and Immune Response of MenABCWY Vaccine in Healthy Adolescents Aged 11-14 with Meningococcal Meningitis

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan and Drug Combination for Patients with HER2-Positive Gastric, GEJ, and Esophageal Cancer

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan and Drug Combination for Patients with HER2-Positive Gastric, GEJ, and Esophageal Cancer

Primary myelofibrosis

Study of Momelotinib and Luspatercept for Patients with Transfusion-Dependent Myelofibrosis

Glioma

Study on the Safety and Effectiveness of Vorasidenib and Temozolomide for Patients with IDH1 or IDH2 Mutant Glioma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.